Psychopathology, psychosocial functioning, and IQ before and after epilepsy surgery in children with drug-resistant

Susanna Danielsson1, Gerd Viggedal, Suzanne Steffenburg

  • 1Department of Pediatrics, Child Neuropsychiatry (BNK), Queen Silvia Children's Hospital, Göteborg, Sweden. susanna.danielsson@vgregion.se

Epilepsy & Behavior : E&B
|November 26, 2008
PubMed

Insights

Children with drug-resistant epilepsy often have co-occurring psychiatric disorders like ADHD and ASD, which persist post-surgery. Many behavioral issues remain undiagnosed, highlighting unmet service needs for these children.

Area of Science:

  • Neuroscience
  • Child Psychiatry
  • Developmental Psychology

Background:

  • Epilepsy surgery in children is a complex intervention.
  • Psychopathology and intellectual functioning are crucial factors in surgical outcomes.
  • Understanding psychosocial functioning is vital for comprehensive care.

Purpose of the Study:

  • To assess psychopathology and IQ heterogeneity in pediatric epilepsy surgery patients.
  • To evaluate psychosocial functioning using the Children's Global Assessment Scale (CGAS).
  • To analyze changes in neuropsychiatric and neuropsychological status at 2-year follow-up.

Main Methods:

  • Prospective study of 24 children undergoing epilepsy surgery.
  • Baseline and 2-year follow-up clinical neuropsychiatric and neuropsychological assessments.
  • Individual-level analysis of changes in functioning and diagnoses.

Main Results:

  • 17 of 24 children had psychiatric disorders (ADHD, ASD) at some point.
  • Psychiatric diagnoses largely persisted post-surgery.
  • Intellectual ability remained stable for most children.
  • CGAS scores reflected significant psychosocial challenges due to comorbidity.

Conclusions:

  • Co-occurring psychiatric disorders are common and persistent in pediatric epilepsy surgery candidates.
  • Behavioral problems are often unrecognized, indicating a gap in services.
  • Comprehensive assessment and integrated care are essential for children with drug-resistant epilepsy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...